NCT05447910 2025-06-15
Analysis of Letrozole in Patients With Operable Hormone Receptor Positive, HER2 Negative Breast Cancer
Mayo Clinic
Terminated
Mayo Clinic
Ohio State University Comprehensive Cancer Center
University of Southern California
National Institutes of Health Clinical Center (CC)